EE-7938. Vacunación infantil sistemática en pandemia: coberturas mantenidas y mejoradas

Autor: I. Huerta González, M. Huerta Huerta

Publikováno v: Vacunas. 23:35

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6227ac883d6c317866da1988a8dd3e4c
https://doi.org/10.1016/j.vacun.2022.09.061

Interim 2022/23 influenza vaccine effectiveness: six European studies, October 2022 to January 2023.

Autor: Kissling E; Epiconcept, Paris, France., Maurel M; Epiconcept, Paris, France., Emborg HD; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark., Whitaker H; UK Health Security Agency, London, United Kingdom., McMenamin J; Public Health Scotland, Glasgow, United Kingdom., Howard J; Epiconcept, Paris, France., Trebbien R; Department of Virus and Microbiological Special diagnostics, National Influenza Center, Statens Serum Institut, Copenhagen, Denmark., Watson C; UK Health Security Agency, London, United Kingdom., Findlay B; Public Health Scotland, Glasgow, United Kingdom., Pozo F; National Centre for Microbiology, National Influenza Reference Laboratory, WHO-National Influenza Centre, Institute of Health Carlos III, Madrid, Spain.; CIBER de Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid, Spain., Bolt Botnen A; Department of Virus and Microbiological Special diagnostics, National Influenza Center, Statens Serum Institut, Copenhagen, Denmark., Harvey C; Public Health Scotland, Glasgow, United Kingdom., Rose A; Epiconcept, Paris, France.

Publikováno v: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2023 May; Vol. 28 (21).